Creation and implantation of acellular rat renal ECM-based scaffolds

Organogenesis

Volumn 11, Issue 2, 2015, Pages 58-74

  Peloso, Andrea ^a   Ferrario, Jacopo ^a   Maiga, Benedetta ^a   Benzoni, Ilaria ^a   Bianco, Carolina ^a   Citro, Antonio ^b   Currao, Manuela ^c   Malara, Alessandro ^c   Gaspari, Annalisa ^a   Balduini, Alessandra ^c,d   Abelli, Massimo ^a   Piemonti, Lorenzo ^b   Dionigi, Paolo ^a   Orlando, Giuseppe ^e   Maestri, Marcello ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^d TUFTS UNIVERSITY   (United States)

^e WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Bioscaffold; Extracellular matrix; Kidney transplantation; Organ bioengineering; Rat model; Regenerative medicine; Scaffold

Indexed keywords

COLLAGEN; LAMININ; TRITON X 100;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOENGINEERING; CELL VIABILITY; CONTROLLED STUDY; EXTRACELLULAR MATRIX; IMPLANTATION; KIDNEY PARENCHYMA; MALE; NONHUMAN; ORGAN PERFUSION; RAT; REGENERATIVE MEDICINE; TISSUE SCAFFOLD; UNINEPHRECTOMY; ANIMAL; CELL FREE SYSTEM; CHEMISTRY; CYTOLOGY; DEVICE FAILURE ANALYSIS; DEVICES; GROWTH, DEVELOPMENT AND AGING; KIDNEY; LEWIS RAT; PROSTHESIS DESIGN; TISSUE ENGINEERING; TRANSPLANTATION;

ANIMALS; CELL-FREE SYSTEM; EQUIPMENT FAILURE ANALYSIS; EXTRACELLULAR MATRIX; KIDNEY; MALE; PROSTHESIS DESIGN; RATS; RATS, INBRED LEW; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84945195176     PISSN: 15476278     EISSN: 15558592     Source Type: Journal    
DOI: 10.1080/15476278.2015.1072661     Document Type: Article

References (33)

1. Willet JD, Pichitsri W, Jenkinson SE, Brain JG, Wood K, Alhasan AA, Spielhofer J, Robertson H, Ali S, Kirby JA. Kidney transplantation: analysis of the expression and T cell mediated activation of latent TGF-b. J Leukoc Biol 2013; 93: 471-8; PMID: 23192429; http://dx. doi. org/10. 1189/jlb. 0712324.
2. Ingelfinger JR, Alexander SI. One step closer to "Rejectostix". N Engl J Med. 2013; 369: 84-5; PMID: 23822781; http://dx. doi. org/10. 1056/NEJMe 1307013.
3. Grzelak P, Szymczyk K, Strzelczyk J, Kurnatowska I, Sapieha M, Nowicki M, Stefanczyk L. Perfusion of kidney graft pyramids and cortex in contrastenhanced ultrasonography in the determination of the cause of delayed graft function. Ann Transplant 2011; 16: 48-53; PMID: 21436774.
4. Dantal J, Soulillou JP. Immunosuppressive drugs and the risk of cancer after organ transplantation. N Eng J Med 2005; 352: 1371-3; http://dx. doi. org/10. 1056/NEJMe058018.
5. United States Renal Data System. Excerpts from USRDS 2009 annual data report. U. S. Department of Health and Human Services. The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Am J Kidney Dis 2010; 55 (suppl 1).
6. Serur D, Charlton M. Expanded criteria living donors: how far can we go? Prog Transplant 2012; 22: 129-32; PMID: 22878068; http://dx. doi. org/10. 7182/pit2012244.
7. Molnar MZ, Streja E, Kovesdy CP, Shah A, Huang E, Bunnapradist S, Krishnan M, Kopple JD, Kalantar-Zadeh K. Age and the associations of living donor and expanded criteria donor kidneys with kidney transplant outcomes. Am J Kidney Dis 2012; 59: 841-8; PMID: 22305759; http://dx. doi. org/10. 1053/j. ajkd. 2011. 12. 014.
8. Reich DJ, Guy SR. Donation after cardiac death in abdominal organ transplantation. Mt Sinai J Med 2012; 79: 365-75; PMID: 22678860; http://dx. doi. org/10. 1002/msj. 21309.
9. Deng R, Gu G, Wang D, Tai Q, Wu L, Ju W, Zhu X, Guo Z, He X. Machine perfusion versus cold storage of kidneys derived from donation after cardiac death: a meta-analysis. PLoS One 2013; 8(3): e56368.
10. Daar AS, Greenwood HL. A proposed definition of regenerative medicine. J Tissue Eng Regen Med 2007; 1: 179-84; PMID: 18038409; http://dx. doi. org/10. 1002/term. 20.
11. Atala A. Engineering organs. Curr Opin Biotechnol 2009; 20: 575-92; PMID: 19896823; http://dx. doi. org/10. 1016/j. copbio. 2009. 10. 003.
12. Vacanti JP, Langer R. Tissue engineering: the design and fabrication of living replacement devices for surgical reconstruction and transplantation. The Lancet 1999; 354: 32-34; http://dx. doi. org/10. 1016/S0140-6736(99)90247-7.
13. MacNeill BD, Pomerantseva I, Lowe HC, Vacanti JP. Toward a new blood vessel. Vasc Med 2002; 7(3): 241-6; PMID: 12553747; http://dx. doi. org/10. 1191/1358863x02vm433ra.
14. Jungebluth P, Moll G, Baiguera S, Macchiarini P. Tissue-engineered airway: a regenerative solution. Clin Pharmacol Ther 2012; 91: 81-93; PMID: 22130120; http://dx. doi. org/10. 1038/clpt. 2011. 270.
15. Atala A, Bauer SB, Soker S, Yoo JJ, Retik AB. Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet 2006; 367: 1241-6; PMID: 16631879; http://dx. doi. org/10. 1016/S0140-6736(06)68438-9.
16. Badylak SF, Taylor D, Uygun K. Whole-organ decellularization and recellularization of three-dimensional matrix scaffolds. Annu Rev Biomed Eng 2011; 13: 27-53; PMID: 21417722; http://dx. doi. org/10. 1146/annurev-bioeng-071910-124743.
17. Booth C, Soker T, Baptista P, Ross CL, Soker S, Farooq U, Stratta RJ, Orlando G. Liver bioengineering: current status and future perspectives. World J Gastroenterol 2012; 18: 6926-34; PMID: 23322990; http://dx. doi. org/10. 3748/wjg. v18. i47. 6926.
18. Chen H, Liu Y, Jiang Z, Chen W, Yu Y, Hu Q. Cellscaffold interaction within engineered tissue. Exp Cell Res 2014, 323: 346-51; PMID: 24631290; http://dx. doi. org/10. 1016/j. yexcr. 2014. 02. 028.
19. Ott HC, Matthiesen TS, Goh SK, Black LD, Kren SM, Netoff TI, Taylor D. Perfusion-decellularized matrix: using nature platform to engineer a bio-artificial heart. Nat Med 2008; 14: 213-21; PMID: 18193059; http://dx. doi. org/10. 1038/nm1684.
20. Ren H, Shi X, Tao L, Xiao J, Zhang Y, Yuan X, Ding Y. Evaluation of two decellularization methods in the development of a whole-organ decellularized rat liver scaffold. Liver int 2013; 33: 448-58; PMID: 23301992; http://dx. doi. org/10. 1111/liv. 12088.
21. Maghsaudlou P, Totinelli G, Lankogeargakis SP, Eaton S, De Coppi P. A decellularization methodology for the production of a natural acellular intestinal matrix. J Vis Exp 2013; 7: 80.
22. Malara A, Currao M, Gruppi C, Celesti V, Viarengo G, Buracchi C, Laghi L, Kaplan DL, Balduini A. Megakaryocytes contribute to the bone marrowmatrix environment by expressing fibronectine, type IV collagen and laminin. Stem Cells 2014; 32: 926-37; PMID: 24357118; http://dx. doi. org/10. 1002/stem. 1626.
23. Badylak SF, Gilbert TW. Immune response to biologic scaffold materials. Seminars in Immunology. Amsterdam Elsevier 2008; 109-116.
24. Ishii E, Shimizu A, Takahashi M, Terasaki M, Kunugi S, Nagasaka S, Terasaki Y, Ohashi R, Masuda Y, Fukuda Y. Surgical technique of orthotopic liver transplantation in rats: the Kamada technique and a new splint technique for hepatic artery reconstruction. J Nippon Med Sch 2013; 80: 4-15.
25. Caralt M, Uzarski JS, Iacob S, Obergfell KP, Berg N, Bijonowski BM, Kiefer KM, Ward HH, Wandinger-Ness A, Miller WM, et al. Optimization and critical evaluation of decellularization strategies to develop renal extracellular matrix scaffolds as biological templates for organ engineering and transplantation. Am J Transplantation 2015; 15: 64-75; http://dx. doi. org/10. 1111/ajt. 12999.
26. Jiang WC, Cheng YH, Yen MH, Chang Y, Yang VW, Lee OK. Cryo-chemical decellularization of the whole liver for mesenchymal stem cells-based functional hepatic tissue engineering. Biomaterials 2014; 35: 3607-17; PMID: 24462361; http://dx. doi. org/10. 1016/j. biomaterials. 2014. 01. 024.
27. Bonandrini B, Figliuzzi M, Papadimou E, Morigi M, Perico N, Casiraghi F, Dipl C, Sangalli F, Conti S, Benigni A, et al. Recellularization of well-preserved acellular kidney scaffold using embryonic stem cells. Tissue Eng Part A 2014; 20: 1486-98; PMID: 24320825; http://dx. doi. org/10. 1089/ten. tea. 2013. 0269.
28. Gilbert TW, Sellaro TL, Badylak SF. Decellularization of tissue and organs. Biomaterials 2006; 27: 3675-83; PMID: 16519932.
29. Cartmell JS, Dunn MG. Effect of chemical tretaments on tendon cellularity and mechanical properties. J Biomed Mater Res 2000; 49: 134-40; PMID: 10559756; http://dx. doi. org/10. 1002/(SICI)1097-4636(200001)49: 1%3c134:: AID-JBM17%3e3. 0. CO; 2-D.
30. Gratzer PF, Harrison RD, Woods T. Matrix alterations and not residual sodium dodecyl sulfate cytotoxicity affects the cellular repopulation of a decellularized matrix. Tissue Eng 2006; 12: 2975-83; PMID: 17518665; http://dx. doi. org/10. 1089/ten. 2006. 12. 2975.
31. Humphrey JD, Dufresne ER and Schwartz MA. Mechanotransduction and extracellular matrix homeostasis. Nat Rev Mol Cell Biol 2014; 15: 802-812; PMID: 25355505; http://dx. doi. org/10. 1038/nrm3896.
32. Chen H, Zhang Y, Zheng D, Praseedon RK, Dang J. Orthotopic kidney transplantation in mice: technique using cuff for renal vein anastomosis. PlosOne 2013; 14: 8.
33. Song JJ, Guyette JP, Gilpin SE, Gonzalez G, Vacanti JP, Ott HC. Regeneration and experimental orthotopic transplantation of a bioengineered kidney. Nat Med 2013; 19: 646-51; PMID: 23584091; http://dx. doi. org/10. 1038/nm. 3154.